THE TREATMENT REVIEW JOURNALVOL. 01 / OCTOBER 2026
CoreAge Rx Review.
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
The reading room

Prescription, compounded or supplement: know the category

A prescription requirement, FDA approval and a supplement label describe different things. Understanding the category helps you ask the right questions.

FEATURED PARTNER · COREAGE RXExplore the provider
OUR TAKE

A prescription requirement, FDA approval and a supplement label describe different things. Understanding the category helps you ask the right questions.

A prescription is a care requirement

A prescription indicates that a clinician must authorize a particular treatment. It does not automatically mean the finished product is FDA-approved. CoreAge Rx’s catalog includes compounded prescription products as well as non-prescription supplements.[source]

Likewise, a product sold without consultation is not automatically suitable for everyone. The purchase route and the strength of clinical evidence are separate issues. Read the specific product description and label.

Approval applies to a defined product

An FDA-approved medicine has been reviewed for its defined uses and comes with product-specific prescribing information. That label identifies the formulation, warnings and evidence. An ingredient name alone does not carry approval to a different finished preparation.

Wegovy and Zepbound are examples covered in this publication through selected access routes. The service that helps a patient obtain a prescription is not itself the medicine, and service marketing cannot broaden the product’s approved claims.[source][source]

Compounding has a different evidence boundary

FDA explains that compounded drugs are not FDA-approved and are not reviewed by the agency for safety, effectiveness and quality before marketing. Compounding can address particular patient needs, but that role does not make every marketed preparation interchangeable with a branded product.[source]

For GLP-1 products, FDA says an approved drug should be used when it can meet the medical need. Ask the prescriber to explain the reason for the compounded preparation and the role of the dispensing pharmacy.[source]

Supplements have their own label and questions

A dietary supplement should have a Supplement Facts panel describing ingredients and amounts per serving. NIH ODS explains that supplements can interact with medicines and that quality seals do not guarantee clinical safety or effectiveness for every individual.[source]

CoreAge Rx GLP-1 Support is a supplement, despite a name that references the same biological pathway as prescription medicines. Strong Suit, Green Scene and Full House also belong to the supplement category. None should inherit a drug’s trial results from shared marketing themes.

Apply the distinction while browsing

Our catalog labels products by category and format. Read those labels before comparing prices or claims. The cheapest supplement, the cheapest compounded medicine and a branded prescription answer different purchasing questions.

No category eliminates the need for a relevant clinical discussion. The useful choice depends on the actual concern, evidence, medical history and practical terms, rather than the assumption that prescription means proven or natural means risk-free.

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.

  1. CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
  2. Wegovy prescribing informationManufacturer labeling; formulation-specific directions and safety information
  3. Zepbound prescribing informationManufacturer prescribing information, warnings and approved uses
  4. FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations
  5. FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags
  6. NIH ODS: dietary supplements, what you need to knowRegulation, interactions, quality and evidence

Keep reading